Авторлор жөнүндө
Мадыбаева Динара Мелисовна, консультант по мониторингу и оценке ОФ «СПИД Фонд Восток-Запад в Кыргызской Республике», Бишкек, Кыргызская Республика
Кулжабаева Айзат Абдыкалыковна, Научный сотрудник Национального центра фтизиатрии Министерства здравоохранения, Бишкек, Кыргызская Республика;Специалист по мони торингу и оценке Общественного Фонда «КНСВ Кей Джи», Бишкек, Кыргызская Республика
Жирнова Елена Алексеевна, менеджер проектов по борьбе с туберкулезом ОФ «СПИД Фонд Восток-Запад в Кыргызской Республике», Бишкек, Кыргызская Республика
Шумская Наталья Адыловна, к.м.н.,Председатель правления ОФ «СПИД Фонд Восток-Запад в Кыргызской Республике», Бишкек, Кыргызская Республика
Madybaeva Dinara Melisovna, Consultant for Monitoring and Evaluation, AIDS Fund East-West in the Kyrgyz Republic, Bishkek, Kyrgyz Republic
Kulzhabaeva Aizat Abdykalykovna, Research Fellow, National Center for Phthisiology, Ministry of Health, Bishkek, Kyrgyz Republic; Monitoring and evaluation specialist Public Foundation "KNСV KG", Bishkek, Kyrgyz Republic
Zhirnova Elena Alekseevna, TB Project Manager, AIDS Fund East-West in the Kyrgyz Republic, Bishkek, Kyrgyz Republic
Natalya Adylovna Shumskaya, Ph.D., Chairperson PF “Public Foundation East-West in the Kyrgyz Republic”, Bishkek, Kyrgyz Republic
Мадыбаева Динара Мелисовна, мониторинг боюнча консультант жана «СПИД Фондунун Чыгыш-Батыш Кыргыз Республикасындагы» КФ, Бишкек, Кыргыз Республикасы
Кулжабаева Айзат Абдыкалыковна, Улуттук илимий кызматкер Улуттук фтизиатрия борбору, Саламаттыкты сактоо министрлиги, Бишкек, Кыргыз Республикасы, KNSV KG коомдук фондунун мониторинг жана баалоо боюнча адиси, Бишкек, Кыргыз Республикасы
Жирнова Елена Алексеевна, каршы күрөшүү боюнча долбоордун жетекчиси «Кыргыз Республикасындагы Чыгыш-Батыш СПИД Фондунун кургак учук» КФсы, Бишкек, Кыргыз Республикасы
Шумская Наталья Адыловна, медицина илимдеринин кандидаты, башкарманын председатели
«СПИД Фондунун Чыгыш-Батыш Кыргыз Республикасындагы» КФ, Бишкек, Кыргыз Республикасы
Шилтемелер
1. National TB program «Tuberculosis 5» 2017-2021.//National TB progressio "Tuberculosis 5" 2017-2021.
2. Global tuberculosis report 2020: executive summary.//Global tuberculosis fama 2020: executive summary.
3. World Health Organization. World Health Organization: DOTS. Geneva: WHO; 2012. Available at: http://who.int/tb/dots/en/ (accessed on November 11, 2014).//Mundus Health Organization. Mundus Health Organization: PUNCTIS. Geneva: QUI; 2012. Available at: http://who.int/tb/dots/en/ (accessed November 11, 2014).
4. Dye C, Maher D, Weil D, Espinal M, Raviglione M. Targets for global tuberculosis control. Int J Tuberc Lung Dis 2016;10:460–2.//Tinctura C, Maher D, Weil D, Espinal M, Raviglione M. Scuta pro global tuberculosis imperium. Int J Tuberc Pulmonis Dis2016;10:460-2.
5. Uplekar M. Involving private health care providers in delivery of TB care: global strategy. Tuberculosis (Edinb) 2003;83:156–64.//Uplekar M. Involvat privata valetudinis curas provisoribus in partus TB cura: global consilio. Tuberculosis (Edinb) 2003;83:156-64.
6. World Health Organization. STOP TB Partnership: DOTS Expansion Working Group Strategic Plan 2006-2015. Geneva: WHO;2006//Mundus Health Organization. PROHIBERE TB Consortium: PUNCTIS Dilatatio Operantes Group Consilium Opportune 2006-2015. Geneva: QUI; 2006
7. Arora V, Jaiswal AK, Gupta S, Gupta MB, Jain V, Ghanchi F. Implementation of RNTCP in a private medical college: five years’experience. Indian J Tuberc 2012;59:145–50. //Arora V, Jaiswal AK, Gupta S, Gupta MB, Jain V, Ghanchi F. Exsecutionem RNTCP in privata medical college: quinque annis' experientia. Indus J Tuberc 2012;59:145-50.
8. Krishnan N, Ananthakrishnan R, Augustine S, Vijayalakshmi NK, Gopi PG, Kumaraswami V, et al. Impact of advocacy on the tuberculosis management 30 X. Lei et al. / International Journal of Infectious Diseases 34 (2015) 20–32 practices of private practitioners in Chennai City, India. Int J Tuberc Lung Dis 2009;13:112–8.//Krishnan N, Ananthakrishnan R, Augustinus, S, Vijayalakshmi NK, Gopi EUTROPIUS, Kumaraswami V, al. Ictum patrocinium in tuberculosis administratione 30 X. Lei et al. / International Journal of Contagione Morbi 34 (2015) 20-32 exercitia privata medicos in Chennai City, India. Int J Tuberc Pulmonis Dis 2009;13:112-8.
9. Rangan SG, Juvekar SK, Rasalpurkar SB, Morankar SN, Joshi AN, Porter JD. Tuberculosis control in rural India: lessons from public–private collaboration. Int J Tuberc Lung Dis 2004;8:552–9.//Rangan SG, Juvekar SK, Rasalpurkar SB, Morankar SN, Joshi AN, Ianitor JD. Tuberculosis imperium in rusticis India: lectiones de publico–privatis collaborationem. Int J Tuberc Pulmonis Dis 2004;8:552-9.
10. Gidado M, Ejembi CL. Tuberculosis case management and treatment outcome: assessment of the effectiveness of Public–private Mix of tuberculosis programme in Kaduna State, Nigeria. Ann Afr Med 2009;8:25–31//Gidado M, Ejembi CL. Tuberculosis casuadministratione et curatio exitus: taxationem efficaciam Publico–privatis Misce tuberculosis suspendisse in Kaduna rei Publicae, Nigeria. Ann Afr Med 2009;8:25-31
11. World Health Organization et al. Involving private medical practitioners in TB and STI control. – WHO Regional Office for South-East Asia, 2001. – №. SEA-TB-235.
12. Munsiff SS, Ahuja SD, Li J, Driver CR. Public–private collaboration for multidrug-resistant tuberculosis control in New York City. Int J Tuberc Lung Dis 2006;10:639–48.
1. National TB program «Tuberculosis 5» 2017-2021.//National TB progressio "Tuberculosis 5" 2017-2021.
2. Global tuberculosis report 2020: executive summary.//Global tuberculosis fama 2020: executive summary.
3. World Health Organization. World Health Organization: DOTS. Geneva: WHO; 2012. Available at: http://who.int/tb/dots/en/ (accessed on November 11, 2014).//Mundus Health Organization. Mundus Health Organization: PUNCTIS. Geneva: QUI; 2012. Available at: http://who.int/tb/dots/en/ (accessed November 11, 2014).
4. Dye C, Maher D, Weil D, Espinal M, Raviglione M. Targets for global tuberculosis control. Int J Tuberc Lung Dis 2016;10:460–2.//Tinctura C, Maher D, Weil D, Espinal M, Raviglione M. Scuta pro global tuberculosis imperium. Int J Tuberc Pulmonis Dis2016;10:460-2.
5. Uplekar M. Involving private health care providers in delivery of TB care: global strategy. Tuberculosis (Edinb) 2003;83:156–64.//Uplekar M. Involvat privata valetudinis curas provisoribus in partus TB cura: global consilio. Tuberculosis (Edinb) 2003;83:156-64.
6. World Health Organization. STOP TB Partnership: DOTS Expansion Working Group Strategic Plan 2006-2015. Geneva: WHO;2006//Mundus Health Organization. PROHIBERE TB Consortium: PUNCTIS Dilatatio Operantes Group Consilium Opportune 2006-2015. Geneva: QUI; 2006
7. Arora V, Jaiswal AK, Gupta S, Gupta MB, Jain V, Ghanchi F. Implementation of RNTCP in a private medical college: five years’experience. Indian J Tuberc 2012;59:145–50. //Arora V, Jaiswal AK, Gupta S, Gupta MB, Jain V, Ghanchi F. Exsecutionem RNTCP in privata medical college: quinque annis' experientia. Indus J Tuberc 2012;59:145-50.
8. Krishnan N, Ananthakrishnan R, Augustine S, Vijayalakshmi NK, Gopi PG, Kumaraswami V, et al. Impact of advocacy on the tuberculosis management 30 X. Lei et al. / International Journal of Infectious Diseases 34 (2015) 20–32 practices of private practitioners in Chennai City, India. Int J Tuberc Lung Dis 2009;13:112–8.//Krishnan N, Ananthakrishnan R, Augustinus, S, Vijayalakshmi NK, Gopi EUTROPIUS, Kumaraswami V, al. Ictum patrocinium in tuberculosis administratione 30 X. Lei et al. / International Journal of Contagione Morbi 34 (2015) 20-32 exercitia privata medicos in Chennai City, India. Int J Tuberc Pulmonis Dis 2009;13:112-8.
9. Rangan SG, Juvekar SK, Rasalpurkar SB, Morankar SN, Joshi AN, Porter JD. Tuberculosis control in rural India: lessons from public–private collaboration. Int J Tuberc Lung Dis 2004;8:552–9.//Rangan SG, Juvekar SK, Rasalpurkar SB, Morankar SN, Joshi AN, Ianitor JD. Tuberculosis imperium in rusticis India: lectiones de publico–privatis collaborationem. Int J Tuberc Pulmonis Dis 2004;8:552-9.
10. Gidado M, Ejembi CL. Tuberculosis case management and treatment outcome: assessment of the effectiveness of Public–private Mix of tuberculosis programme in Kaduna State, Nigeria. Ann Afr Med 2009;8:25–31//Gidado M, Ejembi CL. Tuberculosis casuadministratione et curatio exitus: taxationem efficaciam Publico–privatis Misce tuberculosis suspendisse in Kaduna rei Publicae, Nigeria. Ann Afr Med 2009;8:25-31
11. World Health Organization et al. Involving private medical practitioners in TB and STI control. – WHO Regional Office for South-East Asia, 2001. – №. SEA-TB-235.
12. Munsiff SS, Ahuja SD, Li J, Driver CR. Public–private collaboration for multidrug-resistant tuberculosis control in New York City. Int J Tuberc Lung Dis 2006;10:639–48.
1. National TB program «Tuberculosis 5» 2017-2021.//National TB progressio "Tuberculosis 5" 2017-2021.
2. Global tuberculosis report 2020: executive summary.//Global tuberculosis fama 2020: executive summary.
3. World Health Organization. World Health Organization: DOTS. Geneva: WHO; 2012. Available at: http://who.int/tb/dots/en/ (accessed on November 11, 2014).//Mundus Health Organization. Mundus Health Organization: PUNCTIS. Geneva: QUI; 2012. Available at: http://who.int/tb/dots/en/ (accessed November 11, 2014).
4. Dye C, Maher D, Weil D, Espinal M, Raviglione M. Targets for global tuberculosis control. Int J Tuberc Lung Dis 2016;10:460–2.//Tinctura C, Maher D, Weil D, Espinal M, Raviglione M. Scuta pro global tuberculosis imperium. Int J Tuberc Pulmonis Dis2016;10:460-2.
5. Uplekar M. Involving private health care providers in delivery of TB care: global strategy. Tuberculosis (Edinb) 2003;83:156–64.//Uplekar M. Involvat privata valetudinis curas provisoribus in partus TB cura: global consilio. Tuberculosis (Edinb) 2003;83:156-64.
6. World Health Organization. STOP TB Partnership: DOTS Expansion Working Group Strategic Plan 2006-2015. Geneva: WHO;2006//Mundus Health Organization. PROHIBERE TB Consortium: PUNCTIS Dilatatio Operantes Group Consilium Opportune 2006-2015. Geneva: QUI; 2006
7. Arora V, Jaiswal AK, Gupta S, Gupta MB, Jain V, Ghanchi F. Implementation of RNTCP in a private medical college: five years’experience. Indian J Tuberc 2012;59:145–50. //Arora V, Jaiswal AK, Gupta S, Gupta MB, Jain V, Ghanchi F. Exsecutionem RNTCP in privata medical college: quinque annis' experientia. Indus J Tuberc 2012;59:145-50.
8. Krishnan N, Ananthakrishnan R, Augustine S, Vijayalakshmi NK, Gopi PG, Kumaraswami V, et al. Impact of advocacy on the tuberculosis management 30 X. Lei et al. / International Journal of Infectious Diseases 34 (2015) 20–32 practices of private practitioners in Chennai City, India. Int J Tuberc Lung Dis 2009;13:112–8.//Krishnan N, Ananthakrishnan R, Augustinus, S, Vijayalakshmi NK, Gopi EUTROPIUS, Kumaraswami V, al. Ictum patrocinium in tuberculosis administratione 30 X. Lei et al. / International Journal of Contagione Morbi 34 (2015) 20-32 exercitia privata medicos in Chennai City, India. Int J Tuberc Pulmonis Dis 2009;13:112-8.
9. Rangan SG, Juvekar SK, Rasalpurkar SB, Morankar SN, Joshi AN, Porter JD. Tuberculosis control in rural India: lessons from public–private collaboration. Int J Tuberc Lung Dis 2004;8:552–9.//Rangan SG, Juvekar SK, Rasalpurkar SB, Morankar SN, Joshi AN, Ianitor JD. Tuberculosis imperium in rusticis India: lectiones de publico–privatis collaborationem. Int J Tuberc Pulmonis Dis 2004;8:552-9.
10. Gidado M, Ejembi CL. Tuberculosis case management and treatment outcome: assessment of the effectiveness of Public–private Mix of tuberculosis programme in Kaduna State, Nigeria. Ann Afr Med 2009;8:25–31//Gidado M, Ejembi CL. Tuberculosis casuadministratione et curatio exitus: taxationem efficaciam Publico–privatis Misce tuberculosis suspendisse in Kaduna rei Publicae, Nigeria. Ann Afr Med 2009;8:25-31
11. World Health Organization et al. Involving private medical practitioners in TB and STI control. – WHO Regional Office for South-East Asia, 2001. – №. SEA-TB-235.
12. Munsiff SS, Ahuja SD, Li J, Driver CR. Public–private collaboration for multidrug-resistant tuberculosis control in New York City. Int J Tuberc Lung Dis 2006;10:639–48.
